His patented methods on the physicochemical and biological assessment of particles have been used extensively by risk assessors around the world and helped in understanding the effects of particles on human population health. His current nanoscience research focuses on the interactions of engineered nanomaterials (ENMs) with biological systems and the role of ENM structure on bioactivity.
He holds more than a dozen international and United States patents and inventions. He is a co-author of two books, numerous book chapters, and more than two hundred articles in leading journals in his field of research. Dr. Demokritou’s innovative research was highlighted in major mainstream media and online magazines, including articles published in the Economist, NanoWerk, Chemistry World, The Scientist, ACS C&EN News, MIT News, Harvard Gazette, and NPR. Dr. Demokritou is currently the founding Co-Editor in Chief of NanoImpact (Elsevier), a journal that focuses on all aspects of nanosafety research.